SCHEMBL25061111

SCHEMBL25061111

c1ccc2cc3sc(-c4ccc5cc(-c6ccc7cc8sc9c%10cc%11ccccc%11cc%10sc9c8cc7c6)ccc5c4)cc3cc2c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 2/20 0.40
▸ HSD17B1 P14061 1/20 0.39
▸ HSD17B2 P37059 1/20 0.39
▸ ESR1 P03372 9/20 0.39
▸ ESR2 Q92731 9/20 0.39
▸ ERN1 O75460 1/20 0.36
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ NQO1 P15559 1/20 0.35
▸ NQO2 P16083 1/20 0.35
▸ ALOX5 P09917 1/20 0.33
▸ CYP1A1 P04798 2/20 0.33
▸ CYP1B1 Q16678 2/20 0.33
▸ S1PR4 O95977 1/20 0.33
▸ S1PR5 Q9H228 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25061055 1.00 APP (0.40) APPHSD17B1HSD17B2ESR1ESR2
SCHEMBL25061027 0.96 ESR1 (0.42) APPHSD17B1HSD17B2ESR1ESR2
SCHEMBL25061093 0.96 ESR1 (0.42) APPHSD17B1HSD17B2ESR1ESR2
SCHEMBL25061063 0.96 ESR1 (0.42) APPHSD17B1HSD17B2ESR1ESR2
SCHEMBL25061125 0.96 APP (0.42) APPHSD17B1HSD17B2ESR1ESR2
SCHEMBL25061058 0.96 APP (0.42) APPHSD17B1HSD17B2ESR1ESR2
SCHEMBL25061086 0.96 APP (0.42) APPHSD17B1HSD17B2ESR1ESR2
SCHEMBL25061148 0.94 APP (0.48) APPHSD17B1HSD17B2ESR1ESR2
SCHEMBL25061012 0.93 APP (0.42) APPHSD17B1HSD17B2ESR1ESR2
SCHEMBL25061109 0.93 APP (0.42) APPHSD17B1HSD17B2ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230056339-A1 Condensed Polycyclic Aromatic Compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230056339-A1 Condensed Polycyclic Aromatic Compound PAH, AHR, HRH4 APP 2218/4885HSD17B1 2787/4885HSD17B2 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback